Company says it will shell out $450 million in cash for maker of cancer therapies.
Informa: forbes.com/2010/03/10/facet-biotech-abbott-markets-equi
10 de Marzo del 2010 22:32:14 Por: Anita Broker
Categorías: Forbes: Markets News
Company says it will shell out $450 million in cash for maker of cancer therapies.
Informa: forbes.com/2010/03/10/facet-biotech-abbott-markets-equi